Pharmacokinetics of calcitriol and maxacalcitol administered into peritoneal dialysate bags in peritoneal dialysis patients

Peritoneal Dialysis International

Volumn 25, Issue 6, 2005, Pages 570-575

  Hamada, Chieko ^a   Hayashi, Kayo ^a   Shou, Ichiyu ^a   Inaba, Masanori ^a   Ro, Yuuki ^a   Io, Hiroaki ^a   Maeda, Kunimi ^a   Fukui, Mitsumine ^a   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Calcitriol; Maxacalcitol; Secondary hyperparathyroidism

Indexed keywords

22 OXACALCITRIOL; CALCITRIOL; DIALYSIS FLUID; DIANEAL; POLYPROPYLENE; POLYVINYL DERIVATIVE; RESIN;

ADSORPTION; ARTICLE; CASE REPORT; DIALYSATE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FAILURE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SECONDARY HYPERPARATHYROIDISM; STATISTICAL ANALYSIS;

EID: 30944439857     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080502500613     Document Type: Article

References (14)

1. Gallieni M, Brancaccio D, Antonucci F, Bellinghieri G, Carpani P, Cozzolino M, et al. Twice versus thrice weekly administration of intravenous calcitriol in dialysis patients: a randomized prospective trial. Gruppo Italiano di Studio dell'Osteodistrofia Renale. Clin Nephrol 2000; 53: 188-93.
2. Slatopolsky E, Weerts C, Thielan J, Horst R, Harter H, Martin KJ. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients. J Clin Invest 1984; 74:2136-43.
3. Kobayashi T, Tsugawa N, Okano T, Masuda S, Takeuchi A, Kubodera N, et al. The binding properties, with blood proteins, and tissue distribution of 22-oxa-1 alpha,25-dihydroxyvitamin D3, a noncalcemic analogue of 1 alpha, 25-dihydroxyvitamin D3, in rats. J Biochem (Tokyo) 1994; 115:373-80.
4. Koike N, Hayakawa N, Kumaki K, Stumpf WE. In vivo dose-related receptor binding of the vitamin D analogue [3H]-1,25-dihydroxy-22-oxavitamin D3 (OCT) in rat parathyroid, kidney distal and proximal tubules, duodenum, and skin, studied by quantitative receptor autoradiography. J Histochem Cytochem 1998; 46:1351-8.
5. Denda M, Finch J, Brown AJ, Nishii Y, Kubodera N, Slatopolsky E. 1,25-dihydroxyvitamin D3 and 22-oxacalcitriol prevent the decrease in vitamin D receptor content in the parathyroid glands of uremic rats. Kidney Int 1996; 50:34-9.
6. Kane M, Jay M, Deluca PP. Binding of insulin to a continuous ambulatory peritoneal dialysis system. Am J Hosp Pharm 1986; 43:81-90.
7. Quellhorst E. Insulin therapy during peritoneal dialysis: pros and cons of various forms of administration. J Am Soc Nephrol 2002; 13(Suppl):S92-6.
8. Johnson CA, Amidon G, Reichert JE, Porter WR. Adsorption of insulin to the surface of peritoneal dialysis solution containers. Am J Kidney Dis 1983; 3:224-8.
9. Chan E, Montgomery PA. Administration of insulin by continuous ambulatory peritoneal dialysis. Pharmacotherapy 1993; 13:455-60.
10. Lee MG. Sorption of four drugs to polyvinyl chloride and polybutadiene intravenous administration sets [Published erratum appears in Am J Hosp Pharm 1986; 43:2742]. Am J Hosp Pharm 1986; 43:1945-50.
11. Vieth R, Ledermann SE, Kooh SW, Balfe JW. Losses of calcitriol to peritoneal dialysis bags and tubing. Perit Dial Int 1989; 9:277-80.
12. Teramoto T, Endo K, Ikeda K, Kubodera N, Kinoshita M, Yamanaka M, et al. Binding of vitamin D to low-density-lipoprotein (LDL) and LDL receptor-mediated pathway into cells. Biochem Biophys Res Commun 1995; 215:199-204.
13. Rolla D, Paoletti E, Marsano L, Mulas D, Peloso G, Cannella G. Effects of subcutaneous calcitriol administration on plasma calcium and parathyroid hormone concentrations in continuous ambulatory peritoneal dialysis uremic patients. Perit Dial Int 1993; 13:118-21
14. Salusky IB, Goodman WG, Horst R, Segre GV, Kim L, Norris KC, et al. Pharmacokinetics of calcitriol in continuous ambulatory and cycling peritoneal dialysis patients. Am J Kidney Dis 1990; 16:126-32.